Esophagitis Dissecans Superficialis Due to Possible Fishbone Ingestion: A Case Report
Abstract
Introduction: Esophagitis Dissecans Superficialis (EDS) is a rare, underrecognized mucosal disorder of the esophagus. It is often associated with certain medications, systemic diseases, or direct esophageal trauma. Diagnosis is challenging due to its overlap with other esophageal conditions and the lack of standardized criteria.
Case presentation: We report the case of a 38-year-old woman presenting with acute chest pain, dysphagia, and hematemesis following suspected fishbone ingestion. Initial endoscopic findings revealed sloughed esophageal mucosa with friability predominantly in the upper and mid-esophagus. Supportive management with high-dose proton pump inhibitor therapy and dietary modification resulted in rapid clinical improvement. Follow-up endoscopy at day 56 demonstrated complete resolution of mucosal abnormalities, and esophageal biopsies showed normal squamous epithelium. Based on the characteristic endoscopic findings, exclusion of alternative diagnoses, and benign, self-limited course, the presentation was most consistent with EDS, with fishbone ingestion considered a probable precipitating factor.
Conclusion: This case highlights mechanical esophageal trauma due to possible fishbone ingestion as a rare but plausible trigger for EDS and underscores the importance of recognizing this entity in patients presenting with acute chest pain and upper gastrointestinal bleeding. Increased awareness of EDS may facilitate accurate diagnosis and prevent unnecessary…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.